Costs and Consequences of Using Interferon-γ Release Assays for the Diagnosis of Active Tuberculosis in India.

There is growing concern that interferon-γ release assays (IGRAs) are being used off-label for the diagnosis of active tuberculosis (TB) disease in many high-burden settings, including India, where the background prevalence of latent TB infection is high. We analyzed the costs and consequences of us...

Full description

Bibliographic Details
Main Authors: Kristen M Little, Madhukar Pai, David W Dowdy
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4412573?pdf=render